Prediction of sudden death in elderly patients with heart failure

Ana Ayesta1, Helena Martínez-Sellés2, Antonio Bayés de Luna3

  • 1Cardiology Department, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.

Insights

Sudden cardiac death (SCD) is a major cause of mortality in heart failure (HF). While age is a factor, predicting SCD in elderly HF patients remains challenging, requiring comprehensive risk assessment.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Clinical Research

Background:

  • Sudden cardiac death (SCD) and worsening heart failure (HF) are primary causes of mortality in patients with reduced ejection fraction.
  • Predicting and preventing SCD in elderly patients with HF is complex and often controversial, with limited research including this demographic.
  • Physicians may underestimate SCD risk in older HF patients, attributing mortality primarily to pump failure.

Purpose of the Study:

  • To review the current understanding of SCD prediction in elderly heart failure patients.
  • To highlight the importance of considering age and other clinical factors in SCD risk assessment.
  • To emphasize the need for comprehensive risk scores that account for various SCD mechanisms in older populations.

Main Methods:

  • Literature review and synthesis of existing studies on SCD in heart failure.
  • Analysis of clinical variables, diagnostic tests, and risk scores associated with SCD.
  • Focus on evidence pertaining to elderly populations and their specific risk factors.

Main Results:

  • Age is a significant, though often underestimated, predictor of SCD in heart failure.
  • Clinical factors (symptoms, NYHA class, ischemic cause, comorbidities) and test results (LVEF, natriuretic peptides, arrhythmias) are crucial for risk stratification.
  • Existing risk scores often include age but lack specific validation for elderly HF populations.

Conclusions:

  • A combination of clinical and test markers offers the best approach to predict SCD in heart failure.
  • Risk prediction models should be inclusive of elderly patients and consider all types of SCD, including bradyarrhythmias.
  • Further research is needed to develop and validate specific SCD risk scores for the elderly HF population.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360